Park Ha Biological Technology Co., Ltd. (BYAH) Form 6-K — Sep 11, 2026
Park Ha Biological Technology Co., Ltd. closed a PIPE financing on September 11, 2026, selling 1,080,000 Class A ordinary shares at $2.75 per share to non-U.S. investors for aggregate gross proceeds of approximately $2.97 million before expenses. Investors also received five-year warrants on 1,845,452 additional shares, exercisable immediately at $1.10 per share — 60% below the $2.75 purchase price — with each warrant covering 2.5 shares, implying total potential issuance of roughly 2.9 million shares versus the 1.08 million sold.
Key figures
- Gross Proceeds
- approximately US$2,970,000 (before offering expenses)
- Offering Price
- 2.75
- Shares Offered
- 1080000
- Warrant shares
- 1845452
- Offering exemption
- Regulation S offshore transactions to non-U.S. investors
- Warrant term years
- 5
- Par value per share usd
- 0.008
- Warrant exercise price usd
- 1.1
- Warrant coverage pct derived
- warrant shares equal ~171% of shares purchased
AI analysis
Red flags6 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.